TAP Investigator Initiated Research TAP seeks to advance the delivery of quality medical care and enhance patients' lives by supporting research that contributes to the understanding and treatment of specific disease states. Resources (including funding and study drug) may be available to investigators who are interested in conducting an investigator initiated trial. Investigator Initiated Research (IIR) is defined as unsolicited pre/non-clinical, clinical, health economic and outcome research (HEOR), or systematic article review research studies related to a TAP-supported therapeutic area in which an investigator, or the institution with which the investigator is affiliated, serves as the study's investigator and sponsor, and owner of the data and for which TAP provides support. Access the TAP investigator initiated research website at www.iir-tap.com for more information or to request to be contacted by a TAP medical education and research liaison to discuss a study concept. TAP may support IIR studies that relate to one of the following therapeutic areas of interest:
|
 |
